Individual surveillance using model-based hepatocellular carcinoma risk estimates in chronic hepatitis C patients after antiviral treatment

J Hepatol. 2019 Jan;70(1):209-211. doi: 10.1016/j.jhep.2018.09.016. Epub 2018 Oct 15.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antiviral Agents*
  • Carcinoma, Hepatocellular*
  • Hepatitis C*
  • Hepatitis C, Chronic*
  • Humans
  • Liver Neoplasms*

Substances

  • Antiviral Agents